Zaloguj się

Gotowe bibliografie tematyczne / Endocrine aspects / Artykuły w czasopismach

Artykuły w czasopismach na temat „Endocrine aspects”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Endocrine aspects.

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 30 lipca 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Endocrine aspects”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Akopova, R. A., i T. V. Kokoreva. "ENDOCRINE ASPECTS OF MALE INFERTILITY". Bulletin "Biomedicine and sociology" 3, nr 4 (30.12.2018): 17–19. http://dx.doi.org/10.26787/nydha-2618-8783-2018-3-4-17-19.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Fountoulakis, Stelios, i Agathocles Tsatsoulis. "Molecular genetic aspects and pathophysiology of endocrine hypertension". HORMONES 5, nr 2 (15.04.2006): 90–106. http://dx.doi.org/10.14310/horm.2002.11173.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

KALTENBACH, JANE C. "Endocrine Aspects of Homeostasis". American Zoologist 28, nr 2 (maj 1988): 761–73. http://dx.doi.org/10.1093/icb/28.2.761.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Shalet, SM. "Endocrine aspects of cancer". British Journal of Cancer 70, nr 3 (wrzesień 1994): 569. http://dx.doi.org/10.1038/bjc.1994.347.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Glass, Allan R. "Endocrine Aspects of Obesity". Medical Clinics of North America 73, nr 1 (styczeń 1989): 139–60. http://dx.doi.org/10.1016/s0025-7125(16)30696-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Proietto, Joseph. "Endocrine aspects of obesity". Molecular and Cellular Endocrinology 316, nr 2 (marzec 2010): 103. http://dx.doi.org/10.1016/j.mce.2009.12.004.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Sica, G. "Pathophysiologic and Endocrine Aspects". Journal of International Medical Research 18, nr 1_suppl (styczeń 1990): 8–10. http://dx.doi.org/10.1177/03000605900180s103.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Drent, M. "Endocrine aspects of obesity". Netherlands Journal of Medicine 47, nr 3 (wrzesień 1995): 127–36. http://dx.doi.org/10.1016/0300-2977(95)00008-b.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Vagenakis, A. G. "Endocrine aspects of menopause". Clinical Rheumatology 8, S2 (czerwiec 1989): 48–51. http://dx.doi.org/10.1007/bf02207233.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Rapaport, Robert. "Endocrine Aspects of Aging". Endocrinology and Metabolism Clinics of North America 52, nr 2 (czerwiec 2023): xiii. http://dx.doi.org/10.1016/j.ecl.2023.02.007.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Murialdo, G., i G. Tamagno. "Endocrine aspects of neurosarcoidosis". Journal of Endocrinological Investigation 25, nr 7 (lipiec 2002): 650–62. http://dx.doi.org/10.1007/bf03345093.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Aboimova, E. V., i G. A. Azamatova. "Endocrine ophthalmopathy: historical aspects". Modern technologies in ophtalmology, nr 5 (6.10.2023): 7–10. http://dx.doi.org/10.25276/2312-4911-2023-5-7-10.

Pełny tekst źródła

Streszczenie:

The article presents the history of the development of the treatment of endocrine ophthalmopathy from the first mention of disparate symptoms of the disease in 110 ad to the principles of therapy accepted today. Caleb parry was the first to describe 8 such patients, but his work did not attract the attention of the medical community. In 1835, the Englishman robert graves, in his «clinical lectures», described 3 patients with a disease that was later named after him. a little later, the clinical cases of 4 patients were presented by Karl Basedow, who also suggested that the body was «poisoned» with a toxin as a result of the disease. treatment of toxic goiter with exophthalmos remained symptomatic for a long time. Surgery was resorted to as a «treatment of despair» in neglected patients, which led to high mortality after operations. attempts at surgical intervention on the eye sockets were also ineffective. But at the beginning of the 20th century, several discoveries were made that significantly influenced the effectiveness of treatment. Since 1902, x-ray and then radioisotope irradiation of the thyroid gland entered clinical practice, which led to the recovery of 2/3 of patients. developing after radiotherapy and surgery, hypothyroidism began to stop thyroxine, synthesized in 1926 by charles harrington. the discovery of the thyrostatic properties of thiourea by Edwin astwood in 1946 made it possible to significantly improve the effectiveness of the treatment of patients with hyperthyroidism. the modern era in the treatment of endocrine ophthalmopathy began in the 90s of the last century, when pulse therapy with high doses of glucocorticoid hormones was first proposed. therapy with high-dose corticosteroids remains the «gold standard» for the treatment of endocrine ophthalmopathy to this day. Keywords: endocrine ophthalmopathy, exophthalmos, goiter, thyroid gland, study history

Style APA, Harvard, Vancouver, ISO itp.

13

Sonino, N., J. Guidi i GA Fava. "Psychological aspects of endocrine disease". Journal of the Royal College of Physicians of Edinburgh 45, nr 1 (2015): 55–59. http://dx.doi.org/10.4997/jrcpe.2015.113.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Ilić, Saša, Draško Gostiljac, Vesna Dimitrijević-Srećković i Srđan Popović. "Endocrine aspects of Crohn's disease". Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma 24, nr 74 (2019): 7–18. http://dx.doi.org/10.5937/medgla1973007i.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Sahin, Ozlem G., Elçin Kartal i Nusret Taheri. "Meibomian Gland Dysfunction: Endocrine Aspects". ISRN Ophthalmology 2011 (20.10.2011): 1–6. http://dx.doi.org/10.5402/2011/465198.

Pełny tekst źródła

Streszczenie:

Purpose. To compare the hormone levels of patients with seborrheic meibomian gland dysfunction with controls. Procedures. This is a retrospective case-control study involving 50 patients and 50 controls. Blood workup for hormones was studied in both groups by using macroELISA (enzyme-linked immunosorbent assay). Statistical evaluation was done by using SPSS 15.0 independent samples -test. Results. There were statistically significant differences of serum testosterone and dehydroepiandrosterone sulphate levels between patients and controls (P = 0.000). Female gender showed statistically significant differences of serum thyroid-stimulating hormone and prolactin levels between patients and controls (P = 0.014 and P = 0.043), in addition to serum testosterone and dehydroepiandrosterone sulphate levels (P = 0.000 and P = 0.001). However, male gender showed statistically significant differences of only serum testosterone and dehydroepiandrosterone sulphate levels between patients and controls. (P = 0.003 and P = 0.003 resp.). Conclusions. Increased serum levels of testosterone and dehydroepiandrosterone sulphate in both genders should be considered as diagnostic markers for seborrheic meibomian gland dysfunction.

Style APA, Harvard, Vancouver, ISO itp.

16

Yoo, Hyung Joon. "Antiaging Efforts in Endocrine Aspects". Journal of the Korean Medical Association 50, nr 3 (2007): 234. http://dx.doi.org/10.5124/jkma.2007.50.3.234.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Wu, F. C. W. "Endocrine aspects of anabolic steroids". Clinical Chemistry 43, nr 7 (1.07.1997): 1289–92. http://dx.doi.org/10.1093/clinchem/43.7.1289.

Pełny tekst źródła

Streszczenie:

Abstract Understanding of the mechanism of androgen action has been enhanced by advances in knowledge on the molecular basis of activation of the androgen receptor and the importance of tissue conversion of circulating testosterone to dihydrotestosterone and estradiol. New evidence supports the view that supraphysiological doses of anabolic steroids do have a definite, positive effect on muscle size and muscle strength. However, the nature of the anabolic action of androgens on muscle is currently unclear and may involve mechanisms independent of the androgen receptor. The dose–response relationships of anabolic actions vs the potentially serious risks to health of androgenic-anabolic steroids (AAS) use are still unresolved. Most of the adverse effects of AAS are reversible but some are permanent, particularly in women and children. The reported incidence of acute life-threatening events associated with AAS abuse is low, but the actual risk may be underrecognized or underreported; the exact incidence is unknown. The long-term consequences and disease risks of AAS to the sports competitor remain to be properly evaluated.

Style APA, Harvard, Vancouver, ISO itp.

18

Lizarazo, Adriana Herrera, Michelle McLoughlin i Maria G. Vogiatzi. "Endocrine aspects of Klinefelter syndrome". Current Opinion in Endocrinology & Diabetes and Obesity 26, nr 1 (luty 2019): 60–65. http://dx.doi.org/10.1097/med.0000000000000454.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Higgins, NiallO'. "ENDOCRINE ASPECTS OF BREAST CANCER". ANZ Journal of Surgery 57, nr 10 (październik 1987): 697–701. http://dx.doi.org/10.1111/j.1445-2197.1987.tb01246.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Franks, Stephen. "Endocrine Aspects of Menstrual Disorders". Medicine 29, nr 11 (listopad 2001): 34–37. http://dx.doi.org/10.1383/medc.29.11.34.28432.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Currie, Gemma, David M. Carty, John M. Connell i Marie Freel. "Endocrine aspects of pre-eclampsia". Cardiovascular Endocrinology 4, nr 1 (marzec 2015): 1–10. http://dx.doi.org/10.1097/xce.0000000000000039.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Sonino, Nicoletta, i Giovanni A. Fava. "Psychological aspects of endocrine disease". Clinical Endocrinology 49, nr 1 (lipiec 1998): 1–7. http://dx.doi.org/10.1046/j.1365-2265.1998.00528.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Pantelakis, Chairmen: S., i CR Rodda. "Endocrine aspects of thalassaemia major". Acta Paediatrica 83, s406 (grudzień 1994): 105–6. http://dx.doi.org/10.1111/j.1651-2227.1994.tb13435.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Bravo, Emmanuel L. "Clinical Aspects of Endocrine Hypertension". Medical Clinics of North America 71, nr 5 (wrzesień 1987): 907–20. http://dx.doi.org/10.1016/s0025-7125(16)30816-1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Hofbauer, Lorenz C., Tilman D. Rachner, Robert E. Coleman i Franz Jakob. "Endocrine aspects of bone metastases". Lancet Diabetes & Endocrinology 2, nr 6 (czerwiec 2014): 500–512. http://dx.doi.org/10.1016/s2213-8587(13)70203-1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

Müller, B. "Endocrine aspects of critical illness". Annales d'Endocrinologie 68, nr 4 (wrzesień 2007): 290–98. http://dx.doi.org/10.1016/j.ando.2007.06.006.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Shalet, S. M. "Endocrine Aspects of Acute Illness". Postgraduate Medical Journal 61, nr 722 (1.12.1985): 1099. http://dx.doi.org/10.1136/pgmj.61.722.1099.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Harrison, Timothy S. "Endocrine aspects of acute illness". American Journal of Surgery 151, nr 5 (maj 1986): 639. http://dx.doi.org/10.1016/0002-9610(86)90578-7.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Pervanidou, Panagiota, Evangelia Charmandari i George P. Chrousos. "Endocrine Aspects of Childhood Obesity". Current Pediatrics Reports 1, nr 2 (2.02.2013): 109–17. http://dx.doi.org/10.1007/s40124-013-0011-y.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Boehm, B. O., i N. R. Farid. "Molecular aspects of endocrine autoimmunity". Clinical Investigator 71, nr 1 (styczeń 1993): 79–81. http://dx.doi.org/10.1007/bf00210975.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Beall, G. N. "Immunologic aspects of endocrine diseases". JAMA: The Journal of the American Medical Association 258, nr 20 (27.11.1987): 2952–56. http://dx.doi.org/10.1001/jama.258.20.2952.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Baker, James R. "Immunologic Aspects of Endocrine Diseases". JAMA: The Journal of the American Medical Association 268, nr 20 (25.11.1992): 2899. http://dx.doi.org/10.1001/jama.1992.03490200151017.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

LIECHTY, R. DALE. "Endocrine Aspects of Acute Illness". Archives of Surgery 120, nr 11 (1.11.1985): 1327. http://dx.doi.org/10.1001/archsurg.1985.01390350103032.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Klowden, Marc J. "Endocrine aspects of mosquito reproduction". Archives of Insect Biochemistry and Physiology 35, nr 4 (1997): 491–512. http://dx.doi.org/10.1002/(sici)1520-6327(1997)35:4<491::aid-arch10>3.0.co;2-5.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Baker, J. R. "Immunologic aspects of endocrine diseases". JAMA: The Journal of the American Medical Association 268, nr 20 (25.11.1992): 2899–903. http://dx.doi.org/10.1001/jama.268.20.2899.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

Beall, Gildon N. "Immunologic Aspects of Endocrine Diseases". JAMA: The Journal of the American Medical Association 258, nr 20 (27.11.1987): 2952. http://dx.doi.org/10.1001/jama.1987.03400200158019.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Harrison, Barney. "Endocrine Surgical Aspects of Multiple Endocrine Neoplasia Syndromes in Children". Hormone Research in Paediatrics 68, nr 5 (2007): 105–6. http://dx.doi.org/10.1159/000110590.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

KANNO, Jun. "Endocrine Disrupting Chemicals : Their Biological Aspects". Journal of Synthetic Organic Chemistry, Japan 57, nr 1 (1999): 35–39. http://dx.doi.org/10.5059/yukigoseikyokaishi.57.35.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Larsson, Jörgen. "Endocrine aspects of exocrine pancreatic cancer". International Journal of Pancreatology 12, nr 3 (grudzień 1992): 323. http://dx.doi.org/10.1007/bf02924373.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Nappi, Francesca, Luigi Barrea, Carolina Di Somma, Maria Savanelli, Giovanna Muscogiuri, Francesco Orio i Silvia Savastano. "Endocrine Aspects of Environmental “Obesogen” Pollutants". International Journal of Environmental Research and Public Health 13, nr 8 (28.07.2016): 765. http://dx.doi.org/10.3390/ijerph13080765.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Steller, Michael A., Donald P. Goldstein i Ross S. Berkowitz. "Endocrine Aspects of Gestational Trophoblastic Disease". Endocrinologist 3, nr 2 (marzec 1993): 136–48. http://dx.doi.org/10.1097/00019616-199303000-00009.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Josso, N. "The undervirilized male child: endocrine aspects". BJU International 93, s3 (maj 2004): 3–5. http://dx.doi.org/10.1111/j.1464-410x.2004.04702.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Wierman, Margaret E., Rossella E. Nappi, Nancy Avis, Susan R. Davis, Ferdinand Labrie, Willam Rosner i Jan L. Shifren. "Endocrine Aspects of Women's Sexual Function". Journal of Sexual Medicine 7, nr 1 (styczeń 2010): 561–85. http://dx.doi.org/10.1111/j.1743-6109.2009.01629.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Buvat, Jacques, Mario Maggi, Louis Gooren, Andre T. Guay, Joel Kaufman, Abraham Morgentaler, Claude Schulman i in. "Endocrine Aspects of Male Sexual Dysfunctions". Journal of Sexual Medicine 7, nr 4 (kwiecień 2010): 1627–56. http://dx.doi.org/10.1111/j.1743-6109.2010.01780.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Pichugova, S. V., J. G. Lagereva, I. V. Rybina, S. V. Belyaeva, L. G. Tulakina i Ya B. Beykin. "Immuno-Endocrine Aspects of Male Infertility". Journal of Ural Medical Academic Science 14, nr 2 (2016): 102–25. http://dx.doi.org/10.22138/2500-0918-2016-14-2-102-125.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Barzon, Luisa, Marco Boscaro i Giorgio Palù. "Endocrine Aspects of Cancer Gene Therapy". Endocrine Reviews 25, nr 1 (1.02.2004): 1–44. http://dx.doi.org/10.1210/er.2002-0035.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Davis, Susan R., André T. Guay, Jan L. Shifren i Norman A. Mazer. "Endocrine Aspects of Female Sexual Dysfunction". Journal of Sexual Medicine 1, nr 1 (lipiec 2004): 82–86. http://dx.doi.org/10.1111/j.1743-6109.2004.10112.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Attal, Pierre, i Philippe Chanson. "Endocrine Aspects of Obstructive Sleep Apnea". Journal of Clinical Endocrinology & Metabolism 95, nr 2 (1.02.2010): 483–95. http://dx.doi.org/10.1210/jc.2009-1912.

Pełny tekst źródła

Streszczenie:

Abstract Context: Some endocrine and metabolic disorders are associated with a high frequency of obstructive sleep apnea (OSA), and treatment of the underlying endocrine disorder can improve and occasionally cure OSA. On the other hand, epidemiological and interventional studies suggest that OSA increases the cardiovascular risk, and a link between OSA and glucose metabolism has been suggested, via reduced sleep duration and/or quality. Evidence Acquisition: We reviewed the medical literature for key articles through June 2009. Evidence Synthesis: Some endocrine and metabolic conditions (obesity, acromegaly, hypothyroidism, polycystic ovary disease, etc.) can be associated with OSA. The pathophysiological mechanisms of OSA in these cases are reviewed. In rare instances, OSA may be improved or even cured by treatment of underlying endocrine disorders: this is the case of hypothyroidism and acromegaly, situations in which OSA is mainly related to upper airways narrowing due to reversible thickening of the pharyngeal walls. However, when irreversible skeletal defects and/or obesity are present, OSA may persist despite treatment of endocrine disorders and may thus require complementary therapy. This is also frequently the case in patients with obesity, even after substantial weight reduction. Conclusions: Given the potential neurocognitive consequences and increased cardiovascular risk associated with OSA, specific therapy such as continuous positive airway pressure is recommended if OSA persists despite effective treatment of its potential endocrine and metabolic causes. “Apropos of sleep, that sinister adventure of all our nights, we might say that men go to bed daily with an audacity that would be incomprehensible if we did not know that it is the result of ignorance of the danger.” Charles Baudelaire, in “Fusées, IX”

Style APA, Harvard, Vancouver, ISO itp.

49

Garrigues, Ph. "Endocrine disruptors: Analytical and toxicological aspects". Analusis 28, nr 9 (listopad 2000): 761–62. http://dx.doi.org/10.1051/analusis:2000280761.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Petersén, Åsa, i Maria Björkqvist. "Hypothalamic-endocrine aspects in Huntington's disease". European Journal of Neuroscience 24, nr 4 (sierpień 2006): 961–67. http://dx.doi.org/10.1111/j.1460-9568.2006.04985.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!